What is pathophysiology of Heart attack?

['Mamela leqephe lena']

Pathophysiology ea tlhaselo ea pelo ke eng?

Pathophysiology ea lefu la pelo, le tsejoang hape e le myocardial infarction, e akarelletsa ho sitisoa ha phallo ea mali karolong ea mesifa ea pelo, e lebisang lefung la lisele tsa pelo.

Hangata sena se etsahala ka lebaka la ho thijoa ha tšilo ea pelo ke mali a koetsoeng, e leng se atisang ho bakoa ke lefu la ho thatafala ha methapo ea mali, e leng boemo boo ho lona ho bokellanang mali methapong.

Letlapa lena le entsoe ka k'holeseterole, mafura, litšila tse tsoang liseleng, calcium le fibrin.

Ha plaque e phatloha, e ka etsa hore ho be le mali a koahetsoeng, a ka thibelang tšelo ea mali'me a thibela mali a nang le oksijene hore a se ke a fihla mesifa ea pelo.

Ho haella hona ha oksijene ho etsa hore lisele tsa mesifa ea pelo li shoe, e leng se lebisang ho lefu la pelo.

Tšenyo e bakoang ke lefu lena e itšetlehile ka hore na tšebetso ea mali e etsoa sebakeng se seholo hakae le hore na lefu lena le tšoeroe nako e kae pele ho etsoa phekolo.

Matšoao a lefu la pelo a ka akarelletsa bohloko kapa ho se phutholohe sefubeng, ho hema ka thata, ho nyekeloa ke pelo, ho ba le hlooho e bobebe le bohloko matsohong, molaleng, mohlahareng kapa mokokotlong.

Hangata phekolo ea lefu la pelo e akarelletsa ho khutlisetsa mali mesifeng ea pelo kapele kamoo ho ka khonehang, ebang ke ka meriana kapa ka mekhoa e kang ho koala mali a methapo ea pelo le ho kenya stent kapa ho e potoloha.

Ke habohlokoa ho hlokomela hore pathophysiology ea lefu la pelo e rarahane'me e akarelletsa lintho tse ngata, ho akarelletsa liphatsa tsa lefutso, mokhoa oa bophelo le tikoloho.

Lintho tse ka bakang lefu la pelo ke khatello e phahameng ea mali, k'holeseterole e ngata, ho tsuba, lefu la tsoekere, botenya, ho se ikoetlise le hore lelapa le na le lefu la pelo.

Ho laola lintho tsena tse ka bakang lefu lena ho ka thusa ho fokotsa monyetla oa hore motho a tšoaroe ke lefu la pelo.

['Litšupiso']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Scott J: Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev. 2004, 14 (3): 271-9.

Liu Chung Ming C, Sesperez K, Ben-Sefer E, Arpon D, McGrath K, McClements L, Gentile C: Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease. Cells. 2021, 10 (4): .

Hansen J, Victor RG: Direct measurement of sympathetic activity: new insights into disordered blood pressure regulation in chronic renal failure. Curr Opin Nephrol Hypertens. 1994, 3 (6): 636-43.

LaMacchia JC, Roth MB: Aquaporins-2 and -4 regulate glycogen metabolism and survival during hyposmotic-anoxic stress in Caenorhabditis elegans. Am J Physiol Cell Physiol. 2015, 309 (2): C92-6.

Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR: Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol. 2015, 89 (9): 1401-38.

Lonn E: The clinical relevance of pharmacological blood pressure lowering mechanisms. Can J Cardiol. 2004, 20 Suppl B (): 83B-88B.

['Tlhokomeliso: tsa bongaka']

["Websaete ena e etselitsoe ho ruta le ho fana ka boitsebiso feela'me ha e fane ka keletso ea bongaka kapa litšebeletso tsa litsebi."]

["Boitsebiso bo fanoeng ha boa lokela ho sebelisoa ho hlahloba kapa ho phekola bothata ba bophelo bo botle kapa lefu,'me ba batlang keletso ea bongaka ba lokela ho buisana le ngaka e nang le lengolo la tumello."]

['Ka kōpo hlokomela hore neural net e hlahisang likarabo lipotsong, ha e nepahale haholo-holo ha ho tluoa linomorong.']

["Kamehla batla keletso ea ngaka ea hao kapa mofani e mong ea tšoanelehang oa tlhokomelo ea bophelo mabapi le boemo ba bongaka. Le ka mohla u se ke ua hlokomoloha keletso ea setsebi sa bongaka kapa ua lieha ho e batla ka lebaka la ntho eo u e balileng websaeteng ena. Haeba u nahana hore u ka 'na ua ba le boemo ba tšohanyetso ba bongaka, letsetsa 911 kapa u ee kamoreng ea tšohanyetso e haufi hang-hang. Ha ho kamano ea ngaka le mokuli e bōptjoang ke websaeteng ena kapa tšebeliso ea eona. BioMedLib kapa basebetsi ba eona, kapa motho leha e le ofe ea tlatsetsang ho websaeteng ena, ha a etse litemoso, tse hlakileng kapa tse sa hlakang, mabapi le boitsebiso bo fanoeng mona kapa tšebeliso ea eona."]

['Tlhokomeliso: litokelo tsa bangoli']

['Molao oa Digital Millennium Copyright Act oa 1998, 17 U.S.C. § 512 (DMCA) o fana ka litokelo tsa beng ba litokelo tsa bangoli ba lumelang hore thepa e hlahang Inthaneteng e hatakela litokelo tsa bona tlasa molao oa litokelo tsa bangoli ba U.S. ']

['Haeba u lumela ka tumelo e ntle hore litaba leha e le life kapa thepa e fumanehang mabapi le websaeteng kapa litšebeletso tsa rona e tlōla litokelo tsa hau tsa molao, uena (kapa moemeli oa hau) a ka re romella tsebiso e kōpang hore litaba kapa thepa e tlosoe, kapa ho fihlella ho eona ho thibeloe. ']

['Ditsebiso di tlameha ho romelwa ka lengolo ka imeile (bona karolo ya "Ho iteanya" bakeng sa aterese ya imeile). ']

["DMCA e hloka hore tsebiso ea hao ea ho tlōla ha molao ho boleloang hore e na le boitsebiso bo latelang: (1) tlhaloso ea mosebetsi o sirelelitsoeng ka molao o boleloang hore o tlōloa; (2) tlhaloso ea litaba tse boleloang hore li tlōla molao le boitsebiso bo lekaneng ho re lumella ho fumana litaba; (3) boitsebiso ba ho ikopanya le uena, ho akarelletsa aterese ea hau, nomoro ea fono le aterese ea imeile; (4) polelo ea hau ea hore u na le tumelo e ntle ea hore litaba ka tsela e belaelloang ha e lumelloe ke mong'a litokelo tsa molao, kapa moemeli oa eona, kapa ka ts'ebetso ea molao leha e le ofe; "]

['(5) polelo e saennweng ke wena, tlasa kotlo ya ho hlapanya leshano, ya hore tlhahisoleseding e tsebisong e nepahetse le hore o na le matla a ho tiisa ditokelo tsa mongodi tseo ho thweng di a tlolwa; ']

["le (6) ho saena ka letsoho kapa ka elektronike ha mong'a litokelo tsa bangoli kapa motho ea lumeletsoeng ho nka khato lebitsong la mong'a litokelo tsa bangoli. "]

['Ho hloleha ho kenyelletsa tlhahisoleseding yohle e ka hodimo ho ka baka ho dieha ha ho sebetswa tletlebo ya hao.']

['Ho Iteanya']

['Ka kōpo re romelle imeile ka potso / tlhahiso leha e le efe.']

What is pathophysiology of heart attack?

The pathophysiology of a heart attack, also known as myocardial infarction, involves the disruption of blood flow to a part of the heart muscle, leading to the death of heart cells.

This typically occurs due to the obstruction of a coronary artery by a blood clot, which is often the result of atherosclerosis, a condition where plaque builds up in the arteries.

The plaque is made up of cholesterol, fatty substances, cellular waste products, calcium, and fibrin.

When a plaque ruptures, it can cause a blood clot to form, which can block the artery and prevent oxygen-rich blood from reaching the heart muscle.

This lack of oxygen causes the heart muscle cells to die, leading to a heart attack.

The extent of the damage depends on the size of the area supplied by the blocked artery and the time between the attack and treatment.

Symptoms of a heart attack can include chest pain or discomfort, shortness of breath, nausea, lightheadedness, and pain in the arms, neck, jaw, or back.

Treatment for a heart attack usually involves restoring blood flow to the heart muscle as quickly as possible, either through medication or procedures such as angioplasty and stenting or coronary artery bypass surgery.

It is important to note that the pathophysiology of a heart attack is complex and involves multiple factors, including genetic, lifestyle, and environmental factors.

Risk factors for heart attack include high blood pressure, high cholesterol, smoking, diabetes, obesity, lack of physical activity, and a family history of heart disease.

Managing these risk factors can help reduce the likelihood of experiencing a heart attack.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.